The Differential Gene Expression Profiles between Sensitive and Resistant Breast Cancer Cells to Adriamycin by cDNA Microarray
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
PURPOSE: Adriamycin is one of the most commonly used drugs in the treatment of breast cancer. This study was performed to understand the molecular mechanisms of drug resistance in breast cancer cells. MATERIALS AND METHODS: We have analyzed the MCF-7 breast cell line and its adriamycin-resistant variants, MCF-7/ADR using human 10 K element cDNA microarrays. RESULTS: We defined 68 genes that were up-regulated (14 genes) or down-regulated (54 genes) in adriamycin resistant breast cancer cells. Several genes, such as G protein-coupled receptor kinase 5, phospholipase A2, guanylate cyclase 1, vimentin, matrix metalloproteinase 1 are up-regulated in drug resistant cells. Several genes, such as interferon, alpha-inducible protein 27, forkhead box M1, mitogen-activated protein kinase 6, regulator of mitotic spindle assembly 1 and tumor necrosis factor superfamily are down-regulated in adriamycin resistant cells. The altered expression of genes observed in microarray was verified by RT-PCR. CONCLUSION: These findings show that cDNA microarray analysis can be used to obtain gene expression profiles reflecting the effect of anticancer drugs on breast cancer cells. Such data may lead to the assigning of signature expression profiles of drug-resistant tumors which may help predict responses to drugs and assist in the design of tailored therapeutic regimens to overcome drug resistance.(Cancer Res Treat. 2004;36:43-49)
참고문헌 (25)
- "Cellular resistance to anthracyclines.", 27, pp.251~255 (1996)
- "Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines.", 93, pp.1658~1667 (1999)
- "Myers CE. Adriamycinactivation and oxygen free radical formation in humanbreast tumor cells protective role of glutathione peroxidase inadriamycin resistance. Cancer Res 1989", pp.3844~3848
- "Mechanisms of drug resistance in hematologicmalignancies.", 34, pp.3~8 (1997)
- "Use of cDNA microarray toanalyze gene expression patterns in human cancer.", 14, pp.457~460 (1996)
- "cDNAmicroarray analysis of gene expression profiles associated withcervical cancer.", 35, pp.451~459 (2003)
- "Differential gene expression in retinoic acid-induced differentiation of acute promyelocyteic leukemia cells, NB4 and HL-60 cells.", 296, pp.1125~1133 (2002)
- "Merle P. Separationof mammalian cytochrome c oxidase into 13 polypeptides bya sodium dodecyl sulfate-gel electrophoretic procedure. AnalBiochem 1983", pp.517~521
- "Capaldi RA. Structure and function of cytochrome c oxidase.Annu Rev Biochem 1990", pp.569~596
- "Human cytochrome c oxidase: structure, function and deficiency.", 29, pp.151163~ (1997)
- "Mitochondria as the central controlpoint of apoptosis.", 10, pp.369~377 (2000)
- "Anthracycline-derivedchemotherapeutics in apoptosis and free radical cytotoxicity.", 1, pp.491~494 (1998)
- "Modificationsof oxido-reductase activities in adriamycin-resistantleukemia K562 cells.", 56, pp.451~457 (1998)
- "Alterationsin the expression of cytochrome c oxidase subunits in doxorubicin-resistant leukemia K562 cells.", 63, pp.823~831 (2002)
- "Targeting death and decoy receptors of thetumor-necrosis factor superfamily.", 2, pp.420~430 (2002)
- "Apoptosis andanticancer drug resistance.", 14, pp.211~221 (2001)
- "Cytotoxic drugs and the CD95 pathway.", 13, pp.1854~1858 (1999)
- "cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways", 299, pp.434~441 (2001)
- "Coon JS. Relationship of theexpression of the multidrug resistance gene product in human colon carcinoma to local tumor aggressivenessand lymph node metastasis. Cancer Res 1991", pp.2720~2726
- "Gene expression and amplification inbreast carcinoma cells with intrinsic and acquired doxorubicinresistance.", 20, pp.1300~1306 (2001)
- "Matrix metalloproteinase-7-mediated cleavage of Fas ligandprotects tumor cells from chemotherapeutic drug cytotoxicity.", 61, pp.577~581 (2001)
- "Molecular and cellular biology of intermediate filaments.", 57, pp.593~625 (1988)
- "Loss of epithelialmarkers and acquisition of vimentin expression in adriamycinandvinblastine-resistant haman breast cancer cell lines.", pp.5190~5197 (1992)
- "Different vimentin expressionin two clones derived from a human colocarcinoma cellline showing different sensitivity to doxorubicin.", 71, pp.505~511 (1995)
- "Monitoring theexpression profiles of doxorubicin-induced and doxorubicinresistantcancer cells by cDNA microarray.", 60, pp.4161~4166 (2000)
